macroautophagi
call
autophagi
subject
mani
recent
articl
virologist
regard
herpesvirus
interest
galvan
insight
observ
herp
simplex
viru
neurovirul
protein
bound
beclin
therebi
inhibit
matur
autophagosom
sever
close
relat
herpesvirus
includ
varicellazost
viru
vzv
contain
gene
homolog
genom
autophagi
studi
pursu
viru
investig
differ
base
data
earli
hypothesi
state
autophag
respons
would
impair
vzv
replic
one
initi
method
use
detect
autophagi
microscopi
autophagosom
character
doublewal
outer
membran
contain
microtubuleassoci
protein
light
chain
lipid
form
diamet
autophagosom
nm
immunogen
protein
confoc
microscopi
fluorescentantibodi
probe
excel
method
visual
enumer
autophagosom
vzvinfect
cell
use
technolog
document
abund
autophagi
respons
skin
vesicl
within
exanthem
human
subject
herp
zoster
reproduc
result
infect
cell
cultur
infect
human
skin
xenograft
within
sever
combin
immunodefici
scid
mous
model
varicella
recent
result
duplic
human
skin
organ
cultur
model
herp
zoster
infect
anoth
set
experi
document
autophag
flux
vzvinfect
cell
word
accumul
autophagosom
caus
block
autophagi
pathway
vzv
data
support
paper
report
similar
autophagi
result
infect
close
relat
alphaherpesviru
pseudorabi
viru
prv
well
duck
enter
herpesviru
also
lack
herpesviru
homolog
cell
exhibit
basal
level
autophagi
even
herpesviru
infect
howev
level
autophagi
induc
vzv
infect
human
skin
vzv
diseas
call
herp
zoster
shingl
ii
human
skin
explant
either
skin
organ
cultur
model
sever
combin
immunodefici
mous
model
vzv
infect
far
basal
level
found
inhibit
autophagi
diminish
vzv
celltocel
spread
infect
also
found
evid
intact
autophagi
pathway
requir
vzv
exocytosi
secondari
envelop
find
postul
treatment
vzvinfect
cultur
antiautophag
flux
drug
bafilomycin
baf
would
decreas
viral
titer
baf
known
interrupt
late
stage
flux
includ
fusion
autophagosom
lysosom
endosom
well
fusion
earli
endosom
late
endosom
although
find
treatment
baf
diminish
vzv
titer
find
electron
microscopi
unexpect
insight
also
correl
inhibitori
bafrel
effect
vzv
infecti
cycl
publish
data
inhibitori
effect
brefeldin
monensin
two
golgi
apparatu
locat
prv
infecti
cycl
thu
report
reaffirm
central
golgi
apparatustransgolgi
network
tgn
platform
alphaherpesviru
infecti
cycl
also
expand
antiherpesvir
properti
baf
portion
research
carri
part
honor
undergradu
thesi
research
j
h
girsch
univers
iowa
baf
caus
toxic
cultur
cell
mani
differ
concentr
baf
use
virologist
past
year
tabl
review
paper
list
tabl
found
concentr
equal
less
nm
commonli
select
experi
longer
hour
durat
wherea
higher
baf
concentr
shorter
interv
select
studi
aim
sole
inhibit
viral
entri
studi
vzv
entri
test
toxic
effect
nm
baf
cultur
mrc
monolay
baf
ad
monolay
approxim
confluent
purpos
chose
monolay
less
confluent
vzv
infect
typic
carri
monolay
compound
left
medium
either
h
h
monolay
visual
microscopi
photograph
compar
untreat
control
monolay
appar
addit
baf
medium
inhibit
monolay
reach
confluenc
fig
c
also
enumer
cell
popul
trypan
blue
exclus
addit
baf
h
decreas
cell
count
compar
control
monolay
remov
baf
cell
count
remain
h
later
addit
baf
h
decreas
cell
count
compar
control
monolay
remov
baf
cell
count
decreas
anoth
next
h
next
assess
effect
vzv
infect
baf
treatment
monolay
fig
baf
ad
either
h
postinfect
hpi
hpi
cultur
photograph
hpi
notabl
differ
appear
infect
monolay
treat
baf
uninfect
monolay
treat
baf
word
cytopatholog
primarili
due
baf
treatment
rather
infect
expect
cytopatholog
experi
extens
incub
baf
fig
note
degre
bafinduc
cytopatholog
anticip
read
paper
list
tabl
none
paper
tabl
mention
observ
effect
monolay
treat
lower
concentr
baf
nm
known
properti
baf
inhibit
autophag
flux
predict
product
would
increas
baftreat
cultur
predict
confirm
fig
also
predict
biosynthesi
vzv
glycoprotein
would
decreas
baf
treatment
infect
cultur
carri
experi
infect
monolay
equal
number
infect
cell
treat
monolay
baf
hpi
monolay
baf
hpi
viru
purifi
two
sequenti
sediment
describ
materi
method
three
viru
band
analyz
predomin
viral
glycoprotein
vzv
ge
fig
predict
compar
untreat
control
infect
cultur
rel
amount
ge
declin
monolay
treat
baf
especi
h
subsequ
confirmatori
experi
examin
similarli
treat
monolay
confoc
microscopi
fig
e
expect
baf
treatment
increas
intens
autophagosom
within
cell
decreas
intens
vzv
glycoprotein
express
within
cell
previous
shown
level
vzv
ge
express
increas
first
h
infect
absenc
baf
saw
less
viral
glycoprotein
express
presenc
baf
also
probe
golgi
apparatu
anoth
experi
examin
golgi
apparatu
specif
antibodi
golgi
cisterna
baftreat
infect
cell
appear
disassembl
golgi
cisterna
untreat
infect
cell
fig
g
howev
construct
threedimension
imag
golgi
apparatu
zstack
imari
softwar
golgi
cisterna
disorgan
treat
untreat
infect
cell
fig
g
also
produc
imag
golgi
apparatu
uninfect
cell
golgi
cisterna
label
antibodi
linear
nonstress
cell
see
fig
supplement
materi
base
appear
monolay
baf
treatment
along
decreas
ge
product
predict
vzv
titer
treat
infect
cell
would
lower
titer
untreat
infect
cell
carri
titrat
sonic
disrupt
cell
infect
monolay
incub
obtain
cellfre
vzv
follow
procedur
infect
sonic
titrat
dilut
fig
mark
drop
titer
infect
monolay
treat
baf
h
word
hpi
differ
titer
treat
untreat
monolay
signific
monolay
incub
baf
h
hpi
sonic
titrat
infecti
cellfre
viru
recov
fig
decreas
infect
baf
treatment
substanti
confoc
microscopi
experi
shown
fig
fail
reveal
explan
decid
examin
baftreat
infect
cell
electron
microscopi
base
abrupt
drop
titer
monolay
treat
baf
postul
defect
occur
secondari
envelop
viral
particl
project
acquir
addit
micrograph
baftreat
infect
uninfect
monolay
initi
observ
baftreat
infect
monolay
provid
unanticip
find
name
numer
viral
particl
detect
perinuclear
space
fig
particl
often
typic
structur
primari
envelop
viru
pev
instead
aberr
appear
observ
previous
other
vzvinfect
cell
without
baf
treatment
inspect
appar
vzv
particl
also
found
cytoplasm
often
adjac
golgi
apparatusderiv
vesicl
fig
capsid
also
aberr
appear
fig
although
golgi
cisterna
disrupt
occasion
golgi
apparatu
ci
tran
cisterna
found
howev
unabl
find
evid
wrap
capsid
intact
golgi
cisterna
fig
consider
inspect
micrograph
abl
find
exampl
viru
assembl
compart
vac
vac
baftreat
cell
contain
prototyp
envelop
viral
particl
virion
instead
contain
envelop
particl
without
capsid
presum
light
particl
vari
diamet
vac
locat
near
golgideriv
vacuol
fig
particularli
larg
vac
shown
fig
elong
structur
like
singl
vac
extend
plane
cut
microtom
describ
materi
method
archiv
transmiss
electron
micrograph
vzvinfect
monolay
without
baf
treatment
transmiss
electron
micrograph
view
part
investig
see
fig
supplement
materi
occasion
transmiss
electron
micrograph
includ
unenvelop
viral
particl
cytoplasm
unabl
find
cluster
capsid
cytoplasm
uncommon
find
singl
nake
viral
particl
along
outer
nuclear
membran
onm
infect
cell
occasion
capsid
observ
enter
inner
nuclear
membran
inm
gener
comment
therefor
appear
greater
number
viral
particl
perinuclear
space
within
baftreat
monolay
anoth
control
reexamin
transmiss
electron
micrograph
archiv
select
taken
infect
cell
hpi
low
titer
input
vzv
newli
infect
monolay
show
cytopath
effect
around
hpi
also
low
titer
input
viru
viru
enter
cell
could
easili
detect
transmiss
electron
microscopi
tem
plasma
membran
nuclear
membran
first
hpi
see
fig
supplement
materi
thu
viral
particl
within
nuclear
membran
shown
fig
input
viru
extens
search
literatur
found
transmiss
electron
micrograph
baftreat
monolay
subject
infect
stress
factor
therefor
perform
detail
compar
analysi
baftreat
uninfect
monolay
fig
baf
treatment
led
disorgan
shorten
golgi
cisterna
often
discern
ci
tran
face
fig
larg
cluster
vesicl
often
surround
remnant
cisterna
observ
markedli
increas
number
distinct
vacuol
baftreat
monolay
name
multivesicular
bodi
mvb
readili
detect
untreat
monolay
mvb
close
resembl
morpholog
late
endosomemvb
fraction
describ
earlier
paper
use
baf
mvb
contain
vesicl
twodimension
slice
fig
investig
also
use
term
amphisom
describ
larger
mvb
fill
cargo
also
includ
exampl
golgi
apparatus
uninfect
untreat
cell
fig
f
tubular
structur
typic
tgn
seen
one
micrograph
fig
numer
vesicl
visibl
near
transgolgi
network
mvb
seen
view
baftreat
uninfect
cell
reexamin
chang
organel
cytoplasm
baftreat
infect
cell
particular
found
disassembl
golgi
apparatu
promin
featur
fig
intact
golgi
apparatus
stack
cisterna
rare
present
unabl
locat
capsid
cytoplasm
encircl
golgi
apparatu
membran
evid
secondari
envelop
observ
numer
mvb
also
observ
occasion
endosom
contain
vesicl
also
fragment
golgi
apparatu
stack
fig
c
cytoplasm
vacuol
contain
addit
even
larger
portion
golgi
apparatu
fig
mvb
found
untreat
vzvinfect
cultur
fig
f
observ
second
major
differ
baftreat
infect
cultur
third
day
typic
vzv
infect
numer
virusfil
vacuol
seen
cytoplasm
viral
particl
virion
light
particl
seen
along
plasma
membran
fig
f
contrast
untreat
infect
cultur
cytoplasm
baftreat
monolay
fill
transport
vacuol
contain
prototyp
envelop
viral
particl
viral
particl
align
along
plasma
membran
fig
observ
document
secondarili
envelop
viral
particl
seen
baftreat
cell
use
vacuolar
proton
atpas
inhibitor
baf
studi
confirm
central
golgi
apparatustgn
platform
vzv
infecti
cycl
two
import
conclus
requir
visual
infect
monolay
electron
microscopi
import
conclus
reduc
vzv
titer
secondari
baf
treatment
caus
appar
failur
secondari
envelop
within
vac
capsid
transport
inner
nuclear
membran
detect
within
perinuclear
space
frequent
seen
infect
cell
without
baf
treatment
although
mani
particl
aberr
appear
varieti
similarli
aberr
vzv
particl
seen
previous
vzvinfect
cultur
capsid
exit
onm
detect
within
cytoplasm
often
adjac
golgideriv
vacuol
survey
prior
electron
microscopi
investig
vzv
infecti
cycl
note
virtual
absenc
vzv
capsid
cytoplasm
untreat
infect
cell
human
amnion
cell
human
fibroblast
human
melanoma
cell
document
differ
laboratori
past
year
thu
baf
treatment
led
accumul
capsid
cytoplasm
also
attempt
find
evid
wrap
capsid
within
tgn
unsuccess
extens
search
instead
found
golgideriv
vacuol
contain
viral
particl
resembl
light
particl
particl
contain
envelop
capsid
particl
also
vari
consider
diamet
fail
find
prototyp
envelop
capsid
virion
nm
diamet
within
individu
vesicl
cytoplasm
base
abovement
observ
propos
secondari
envelop
block
baf
treatment
word
capsid
transport
region
tgn
format
compart
requir
tegument
andor
envelop
incom
capsid
disrupt
baftreat
cell
abovement
vzv
data
also
support
model
hsv
assembl
properti
baf
compound
report
landmark
paper
baf
macrolid
antibiot
inhibit
acidpump
function
vacuolar
h
atpas
high
specif
nanomolar
concentr
therefor
baf
treatment
disrupt
function
multipl
acid
organel
within
central
vacuolar
system
cell
within
decad
articl
second
pivot
paper
report
major
impair
autophag
flux
baf
name
baf
treatment
prevent
fusion
autophagosom
lysosom
fig
pathway
effect
presum
caus
inabl
lysosom
maintain
acid
ph
presenc
baf
site
attach
baf
atpas
determin
subsequ
other
found
baf
effect
involv
separ
inhibitori
event
autophagosomelysosom
fusion
autolysosom
acidif
although
autophag
flux
studi
receiv
attent
relat
baf
studi
demonstr
baf
treatment
disrupt
function
golgi
apparatu
especi
acid
transgolgi
tgn
fig
pathway
ii
proof
impair
golgi
apparatu
function
sever
paper
report
baf
treatment
interf
process
complex
nlink
glycan
envelop
virus
exampl
final
process
semliki
forest
viru
sfv
vesicular
stomat
viru
vsv
glycoprotein
addit
virolog
studi
show
failur
influenza
b
viru
replic
presenc
sever
differ
baf
concentr
likewis
replic
block
grown
medium
contain
nm
baf
taken
togeth
virolog
studi
clearli
show
one
compon
baf
inhibitori
effect
impair
envelop
rna
dna
virus
similarli
specul
baf
treatment
vzvinfect
cell
drastic
reduc
number
viru
assembl
compart
effect
tgn
second
conclus
baf
studi
involv
increas
number
mvb
baftreat
cell
investig
earli
studi
origin
mvb
anim
model
use
baf
conclud
vesicl
insid
mvb
deriv
vesicl
found
along
convex
surfac
transgolgi
cisterna
second
group
report
druginduc
disorgan
golgi
apparatu
lead
releas
vesicl
mainli
transgolgi
apparatu
third
group
document
increas
number
mvb
cell
treat
baf
specif
state
baf
treatment
led
notic
declin
lysosom
increas
multivesicular
endosom
transmiss
electron
micrograph
morpholog
mvb
close
resembl
describ
friend
mousavi
et
al
short
examin
baftreat
uninfect
infect
cell
confirm
prior
observ
baf
treatment
led
increas
presenc
mvb
includ
pathway
fig
would
involv
entri
golgi
apparatusderiv
vesicl
releas
disorgan
golgi
apparatu
secondari
baf
treatment
endosom
endosom
sort
complex
requir
transport
escrt
form
mvb
baf
treatment
subsequ
fusion
mvb
lysosom
block
complementari
studi
effect
golgi
apparatu
inhibit
infecti
cycl
prv
brefeldin
inhibit
protein
transport
endoplasm
reticulum
er
cisgolgi
presenc
brefeldin
prv
cross
inm
acquir
envelop
becom
pev
passag
pev
onm
block
brefeldin
monensin
caus
disassembl
vacuol
golgi
apparatu
grown
presenc
monensin
viral
titer
decreas
exocytosi
secondarili
envelop
particl
limit
thu
baf
block
fall
locat
brefeldin
block
monensin
block
alphaherpesviru
infecti
cycl
yet
studi
effect
nocodazol
vzv
assembl
drug
also
block
viral
entri
therefor
addit
nocodazol
cultur
prevent
complet
multistep
growth
curv
h
requir
achiev
suffici
high
vzv
titer
allow
visual
viral
particl
tem
addit
newli
recogn
effect
describ
report
baf
import
drug
investig
herpesviru
entri
tabl
hsv
entri
experi
baf
ad
shortli
viru
inocul
fig
pathway
iii
entri
strain
ko
hela
cell
inhibit
incub
presenc
nm
baf
hpi
baf
treatment
exert
similar
effect
entri
vero
cell
author
conclud
success
entri
hela
cell
requir
endocytosi
traffick
acid
intracellular
endosom
entri
vero
cell
proce
fusion
envelop
glycoprotein
plasma
membran
similar
mode
vzv
entri
endocytosi
rather
fusion
demonstr
vzv
infect
cho
cell
presenc
nm
baf
final
data
contradict
sever
find
prior
report
baf
effect
vzv
infecti
cycl
report
includ
electron
microscopi
baftreat
vzvinfect
cell
fibroblast
atcc
mewo
cell
sloan
ketter
institut
grown
minimum
essenti
medium
mem
life
technolog
supplement
fetal
bovin
serum
lglutamin
nonessenti
amino
acid
penicillinstreptomycin
cell
confluent
inocul
trypsindispers
infect
cell
ratio
one
infect
cell
eight
uninfect
cell
titer
inoculum
million
infecti
fociml
viru
strain
complet
sequenc
lowpassagenumb
strain
bafilomycin
well
rabbit
antibodi
purchas
sigma
toxic
baf
cell
assess
trypan
blue
exclus
golgi
apparatu
antibodi
obtain
thermo
scientif
mous
monoclon
antibodi
mab
vzv
ge
clone
produc
laboratori
secondari
antibodi
includ
goat
antirabbit
alexa
fluor
life
technolog
goat
antimous
alexa
fluor
life
technolog
dna
stain
hoechst
invitrogen
protocol
sediment
vzv
sonic
potassium
tartrateglycerol
gradient
describ
previous
virion
band
gradient
pellet
supernat
discard
pellet
solubil
sdspage
sampl
buffer
tri
ph
sd
betamercaptoethanol
glycerol
bromophenol
blue
solubil
purifi
viru
separ
gradient
sdspage
gel
transfer
polyvinyliden
difluorid
pvdf
membran
membran
block
phosphatebuff
salin
pb
tween
contain
nonfat
dri
milk
min
room
temperatur
incub
primari
antibodi
dilut
tween
milk
h
room
temperatur
membran
wash
time
min
time
room
temperatur
tween
incub
goat
antimous
goat
antirabbit
horseradish
peroxidas
hrp
conjug
secondari
antibodi
dilut
tween
milk
h
room
temperatur
wash
time
min
time
room
temperatur
tween
label
protein
detect
use
supersign
west
pico
plu
chemiluminesc
substrat
kit
thermo
scientif
cell
plate
glass
coverslip
tissu
cultur
plate
incub
confluent
cell
inocul
vzvinfect
cell
ratio
infect
cell
uninfect
cell
infect
cell
treat
nm
bafilomycin
hpi
hpi
cell
fix
paraformaldehyd
triton
room
temperatur
h
fix
cell
wash
time
min
time
pb
block
min
pb
nonfat
dri
milk
coverslip
incub
primari
antibodi
dilut
milk
h
room
temperatur
wash
time
min
time
pb
coverslip
incub
goat
antimous
goat
antirabbit
secondari
antibodi
conjug
alexa
fluor
alexa
fluor
wash
time
min
time
mount
glass
slide
imag
collect
zeiss
laser
scan
confoc
microscop
zstack
imag
convert
imag
imari
softwar
oxford
instrument
cell
cultur
medium
overli
monolay
replac
glutaraldehyd
cacodyl
buffer
prewarm
cell
undergo
fixat
allow
cool
room
temperatur
remain
fix
overnight
rins
sever
time
cacodyl
buffer
postfix
carri
min
osmium
tetroxid
solut
reduc
potassium
ferrocyanid
cacodyl
buffer
solut
second
fix
remov
sever
rins
distil
water
en
bloc
stain
uranyl
acet
done
min
cell
dehydr
use
gradual
increas
concentr
ethanol
point
infiltr
mixtur
epon
epoxi
resin
ted
pella
ethanol
appli
incub
h
room
temperatur
mixtur
replac
resin
three
time
interv
cure
addit
h
oven
section
nm
thick
cut
use
leica
ultramicrotom
collect
formvarco
copper
grid
counterstain
done
uranyl
acet
min
reynold
lead
citrat
min
imag
collect
kv
use
jeol
transmiss
electron
microscop
record
directli
digit
format
gatan
chargecoupleddevic
camera
equip
gatan
microscopi
suit
softwar
retain
archiv
tem
neg
print
laboratori
tem
result
concern
vzv
infecti
cycl
describ
previou
articl
laboratori
publish
imag
select
total
micrograph
taken
separ
experi
subsequ
seri
tem
analys
carri
part
research
master
thesi
total
digit
micrograph
vzvinfect
cell
retain
file
hard
drive
imag
captur
separ
experi
latter
studi
includ
earli
analys
autophagi
vzv
infect
reexamin
imag
part
current
studi
addit
new
imag
collect
part
baf
research
protocol
infect
monolay
statist
analys
shown
fig
perform
student
test
test
describ
detail
previous
